Christiana Stamoulis
Vermogen: 6 M $ op 31-05-2026
Vermogen: 6 M $ op 31-05-2026
Momenteel is Christiana Stamoulis Chief Financial Officer & Executive Vice President van Incyte Corp. Mevrouw Stamoulis zit ook in de raad van bestuur van Hologic, Inc. In haar loopbaan was zij President & Chief Financial Officer bij Cogent Biosciences, Inc., Senior VP-Strategy & Business Development bij Vertex Pharmaceuticals, Inc., Managing Director-Investment Banking Division bij Citigroup, Inc. en Vice President bij Goldman Sachs & Co. LLC. Mevrouw Stamoulis behaalde een bachelorgraad aan het Massachusetts Institute of Technology en een MBA aan de MIT Sloan School of Management.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
INCYTE CORPORATION 0,03% | 14-04-2026 | 57.534 ( 0,03% ) | 6 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| MALLINCKRODT PLC | Financieel Directeur/CFO | 01-09-2025 |
| Bedrijven | Functie | Einde |
|---|---|---|
| HOLOGIC, INC. | Directeur/Bestuurslid | 07-04-2026 |
| INCYTE CORPORATION | Financieel Directeur/CFO | 16-09-2025 |
| COGENT BIOSCIENCES, INC. | Financieel Directeur/CFO | 31-01-2019 |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01-12-2013 |
| CITIGROUP INC. | Corporate Officer/Principal | 01-01-2009 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 9 |
|---|---|
Hologic, Inc.
Hologic, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and supplies diagnostics devices, medical imaging systems & surgical products for women's | Health Technology |
Incyte Corp.
Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Vertex Pharmaceuticals, Inc.
Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Citigroup, Inc.
Citigroup, Inc. Major BanksFinance Provides retail, investment, commercial banking, brand cards, securities sale & exchanges services | Finance |
Keenova Therapeutics Plc
Keenova Therapeutics Plc BiotechnologyHealth Technology Develops therapeutics for rheumatology, ophthalmology, nephrology, neurology, pulmonology, orthopedics, urology and neonatal respiratory problems | Health Technology |
Cogent Biosciences, Inc.
Cogent Biosciences, Inc. BiotechnologyHealth Technology Discovers and develops new cellular immunotherapies for cancer | Health Technology |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
MIT Sloan School of Management
MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau